[Comparative study on the effect of some clinically used sulfanilamide derivatives against toxoplasmosis in the mouse].
D062365:Aminobenzoates / Q000494:pharmacology; D000818:Animals; D003622:Dapsone / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005260:Female; D051379:Mice; D010919:Placebos; D011739:Pyrimethamine / Q000494:pharmacology / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D013416:Sulfamerazine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D013420:Sulfamethoxazole / Q000494:pharmacology; D013449:Sulfonamides / Q000627:therapeutic use*; D013997:Time Factors; D014124:Toxoplasmosis, Animal / Q000188:drug therapy*; D014295:Trimethoprim / Q000494:pharmacology / Q000627:therapeutic use
D062365:Aminobenzoates; D010919:Placebos; D013449:Sulfonamides; D003622:Dapsone; D014295:Trimethoprim; D013420:Sulfamethoxazole; D013416:Sulfamerazine; D011739:Pyrimethamine
Vergleichende Prüfung einiger in der Klinik verwendeter Sulfanilamid-Derivate bei der akuten Toxoplasmose der Maus.